mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
SB 216763 |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
KIN001-135 |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.7 |